Home › Overweight › Mississippi › Jackson
Overweight clinical trials in Jackson, MS
6 studies for Overweight are looking for participants at sites in and around Jackson (within about 30 miles). Open a study to see who can join and how to contact the study team.
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
RecruitingPhase 3
- Jackson Heart Clinic, Jackson
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
RecruitingPhase 3
- AURORA-2 Clinical Site, Jackson
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities
RecruitingPhase 3
- AURORA-1 Clinical Site, Jackson
A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)
RecruitingPhase 3Healthy volunteers welcome
- ACCOMPLISH-2 Research Site, Ridgeland · 9 mi away
Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Cafraglutide in Adults With Obesity or Overweight (MARITIME-SWITCH)
RecruitingPhase 3
- Sky Integrative Medical Center, Ridgeland · 9 mi away
Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)
RecruitingPhase 3
- ACCOMPLISH-1 Research Site, Ridgeland · 9 mi away
Overweight trials in other cities
- San Antonio, TX34 studies
- Houston, TX33 studies
- Chicago, IL27 studies
- Orlando, FL25 studies
- Miami, FL23 studies
- Las Vegas, NV22 studies
- Atlanta, GA21 studies
- Dallas, TX20 studies
- Washington, DC19 studies
- Austin, TX19 studies
- New York City, NY19 studies
- Jacksonville, FL18 studies
Other studies in Jackson
- Obesity8 studies
- Steatotic Liver Disease5 studies
- Non-Small Cell Lung Cancer5 studies
- Lung Cancer5 studies
- Heart Failure5 studies
- Prostate Cancer5 studies
- Type 2 Diabetes5 studies
- Breast Cancer5 studies
- Sickle Cell Disease5 studies
- Attention Deficit Hyperactivity Disorder4 studies
- Burkitt Lymphoma4 studies
- Migraine4 studies
From ClinicalTrials.gov, data retrieved Sep 29, 2026. Each study sets its own eligibility; the study team decides who can join.